Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials
Author:
Affiliation:
1. Biostatistics Unit; Department of Health Sciences; University of Genoa; Genoa Italy
Publisher
Wiley
Subject
Clinical Neurology,Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12690/fullpdf
Reference15 articles.
1. Natural history of multiple sclerosis: long-term prognostic factors;Renoux;Neurol Clin,2011
2. Natural history of multiple sclerosis: early prognostic factors;Mowry;Neurol Clin,2011
3. Determinants of interferon β efficacy in patients with multiple sclerosis;Killestein;Nat Rev Neurol,2011
4. Defining and scoring response to IFNβ in multiple sclerosis;Sormani;Nat Rev Neurol,2013
5. Teriflunomide Multiple Sclerosis Trial Group. Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis;Miller;Mult Scler,2012
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MS treatment de-escalation: review and commentary;Journal of Neurology;2024-08-02
2. Treatment escalation and de-escalation in late-onset MS;Medicom Conference Report EAN 2024;2024-07-25
3. Association of Clinical Relapses With Disease Outcomes in Multiple Sclerosis Patients Older Than 50 Years;Neurology;2024-07-23
4. De-escalation and Discontinuation of Disease-Modifying Therapies in Multiple Sclerosis;Current Neurology and Neuroscience Reports;2024-07-12
5. As time goes by: Treatment challenges in elderly people with multiple sclerosis;Journal of Neuroimmunology;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3